--- title: "An interview with Sriram Krishnan, who says \"there will not be an FDA for AI\" under Trump, blames the AI backlash on the industry's \"doomer\" messaging, and more (Financial Times) | SpinGraph: Regulatory blame shift" description: "SpinGraph analysis of Techmeme's An interview with Sriram Krishnan, who says \"there will not be an FDA for AI\" under Trump, blames the AI backlash on the indus…" canonical: "https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind" html: "https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind" json: "https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind.json" markdown: "https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind.md" keywords: ["AI regulation", "doomer messaging", "Trump administration", "The Shield", "The Cushion"] date: "2026-07-03T15:30:01+00:00" modified: "2026-07-06T09:45:32.775534+00:00" json_ld: | {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://stuffthatspins.com/#organization","name":"Stuff That Spins","url":"https://stuffthatspins.com/","description":"Know the moment AI knows your story. Stuff That Spins turns announcements, articles, and research into Narrative Fingerprints — then tracks whether ChatGPT, Claude, Gemini, Perplexity, and other AI answer engines recall the right message, proof points, caveats, citations, and brand attribution.","logo":{"@type":"ImageObject","url":"https://stuffthatspins.com/images/logo.png"},"sameAs":[]},{"@type":"NewsArticle","@id":"https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind#article","headline":"An interview with Sriram Krishnan, who says \"there will not be an FDA for AI\" under Trump, blames the AI backlash on the industry's \"doomer\" messaging, and more (Financial Times)","alternativeHeadline":"An interview with Sriram Krishnan, who says \"there will not be an FDA for AI\" under Trump, blames the AI backlash on the industry's \"doomer\" messaging, and more (Financial Times) | SpinGraph: Regulatory blame shift","description":"SpinGraph analysis of Techmeme's An interview with Sriram Krishnan, who says \"there will not be an FDA for AI\" under Trump, blames the AI backlash on the indus…","datePublished":"2026-07-03T15:30:01+00:00","dateModified":"2026-07-06T09:45:32.775534+00:00","url":"https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind","mainEntityOfPage":{"@type":"WebPage","@id":"https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind"},"isAccessibleForFree":true,"inLanguage":"en-US","articleSection":"technology","keywords":"AI regulation, doomer messaging, Trump administration, FDA for AI","author":{"@type":"Organization","name":"Techmeme","url":"https://www.techmeme.com/feed.xml"},"publisher":{"@id":"https://stuffthatspins.com/#organization"},"citation":"https://www.techmeme.com/260703/p10#a260703p10","about":[{"@type":"Thing","name":"AI regulation"},{"@type":"Thing","name":"doomer messaging"},{"@type":"Thing","name":"Trump administration"},{"@type":"Thing","name":"FDA for AI"},{"@type":"Person","name":"Sriram Krishnan","url":"https://stuffthatspins.com/entities/sriram-krishnan"}],"mentions":[{"@type":"Organization","name":"Techmeme"},{"@type":"Person","name":"Sriram Krishnan"}],"abstract":"Krishnan asserts no FDA-style AI regulator will emerge under Trump He frames AI backlash as self-inflicted due to pessimistic industry rhetoric The interview positions regulatory resistance as principled, not negligent"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Stuff That Spins","item":"https://stuffthatspins.com/"},{"@type":"ListItem","position":2,"name":"An interview with Sriram Krishnan, who says \"there will not be an FDA for AI\" under Trump, blames the AI backlash on the industry's \"doomer\" messaging, and more (Financial Times)","item":"https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind"}]},{"@type":"AnalysisNewsArticle","@id":"https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind#spin-analysis","headline":"Spin Analysis: regulatory blame shift","description":"Emphasizes industry agency over external pressures; minimizes legitimate concerns driving regulatory momentum (e.g., election interference, labor displacement, bias incidents).","about":{"@type":"DefinedTerm","name":"regulatory blame shift","description":"Industry as self-correcting communicator resisting overreach, not as risk-creating actor needing oversight.","termCode":"The Shield"},"additionalProperty":[{"@type":"PropertyValue","name":"Spin Score","value":78,"unitText":"percent"},{"@type":"PropertyValue","name":"Narrative Risk","value":"moderate"},{"@type":"PropertyValue","name":"AI Repetition Risk","value":"high"},{"@type":"PropertyValue","name":"Likely AI Summary","value":"AI industry leader says there won't be an FDA for AI under Trump and blames AI backlash on doomer messaging."},{"@type":"PropertyValue","name":"Narrative Frame","value":"Industry as self-correcting communicator resisting overreach, not as risk-creating actor needing oversight."},{"@type":"PropertyValue","name":"Missing Context","value":"Specific harms prompting regulatory proposals; Existing bipartisan legislative efforts; Global regulatory developments (EU AI Act, UK approach)"},{"@type":"PropertyValue","name":"How the Spin Works","value":"Combines authoritative sourcing (FT interview), political framing (Trump opposition), and moral labeling ('doomer') to make regulatory resistance feel intellectually coherent and ethically defensible — even though the claim about causality lacks evidence and obscures concrete harms driving actual regulatory proposals."}],"author":{"@id":"https://stuffthatspins.com/#organization"},"isPartOf":{"@id":"https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind#article"}},{"@type":"ItemList","@id":"https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind#claims","name":"Extracted Claims","itemListElement":[{"@type":"ListItem","position":1,"item":{"@type":"Claim","text":"There will not be an FDA for AI under Trump","appearance":"Sriram Krishnan tells the FT the president is against a centralised regulator as AI backlash grows","author":{"@type":"Organization","name":"Techmeme"}}}]},{"@type":"Dataset","@id":"https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind#stats","name":"Key Statistics","description":"Extracted statistics from the source narrative","variableMeasured":[{"@type":"PropertyValue","name":"regulatory context","value":"Trump administration","description":"Political environment shaping AI governance prospects"}]}]} --- # An interview with Sriram Krishnan, who says "there will not be an FDA for AI" under Trump, blames the AI backlash on the industry's "doomer" messaging, and more (Financial Times) **Source:** Unknown **Published:** July 3, 2026 **Original:** https://www.techmeme.com/260703/p10#a260703p10 ## On this page - [Overview](#overview) - [Verdict](#narrative-frame) - [SpinGraph](#spingraph) - [Claim Ledger](#claim-ledger) - [Fact Check Signals](#fact-check-signals) - [Language Heatmap](#language-heatmap) - [Frame Strength](#frame-strength) - [Reader Risk](#reader-risk) - [AI Recall Timeline](#ai-recall) - [Ask AI](#ask-ai) ## Overview Sriram Krishnan claims AI regulation will not be centralized under a Trump administration and attributes growing public skepticism to industry 'doomer' messaging rather than technical or societal risks. ### TL;DR - Krishnan asserts no FDA-style AI regulator will emerge under Trump - He frames AI backlash as self-inflicted due to pessimistic industry rhetoric - The interview positions regulatory resistance as principled, not negligent ### Key Stats - **Trump administration** — regulatory context. Political environment shaping AI governance prospects ## SpinGraph Instead of addressing why people fear AI — like job losses or election manipulation — the story blames those fears on overly negative messaging by other AI insiders, letting current actors off the hook for accountability. - **Claim:** There will not be an FDA for AI under Trump - **Frame:** Regulators blamed for lag - **Beneficiary:** Elevates his profile as a pragmatic, anti-alarmist thought leader - **Gap:** Specific harms prompting regulatory proposals - **AI Risk:** AI may repeat the headline as fact ## Fact Check Signals We searched known fact-check databases for direct or near-direct matches to the article's major claims. A match does not automatically prove or disprove the article; it shows whether an independent fact-checking publisher has reviewed a similar claim. **Signal:** 0 of 1 claim(s) matched (confidence: low). ### There will not be an FDA for AI under Trump - No direct fact-check match found ## Frame Strength - **Spin Score:** 78% - **Evidence Strength:** 25% - **Narrative Risk:** 75% - **AI Repetition Risk:** 90% - **Missing Context Risk:** 80% ## Narrative Mechanics **Function:** shift_responsibility ### The Spin in Plain English Instead of addressing why people fear AI — like job losses or election manipulation — the story blames those fears on overly negative messaging by other AI insiders, letting current actors off the hook for accountability. **What the story wants you to believe:** That AI's regulatory challenges stem from industry's own alarmist communication, not from demonstrable harms or systemic risks. **What it makes harder to question:** Whether industry leaders bear responsibility for real-world AI harms when they dismiss criticism as 'doomer' rhetoric. **How the Spin Works:** Combines authoritative sourcing (FT interview), political framing (Trump opposition), and moral labeling ('doomer') to make regulatory resistance feel intellectually coherent and ethically defensible — even though the claim about causality lacks evidence and obscures concrete harms driving actual regulatory proposals. ### Questions This Story Raises - Who is positioned as responsible? - Who is absolved or minimized? - What accountability mechanisms are missing? - Why does the main frame leave this out: “Specific harms prompting regulatory proposals”? - Why does the main frame leave this out: “Existing bipartisan legislative efforts”? ### Who Benefits If This Frame Spreads - **Sriram Krishnan** — Elevates his profile as a pragmatic, anti-alarmist thought leader _(Positioning himself against both 'doomers' and regulators reinforces authority without requiring technical or policy specificity.)_ ## Narrative Frame **Tactic:** regulatory blame shift **Category:** The Shield + The Cushion **Spin Score:** 78% Emphasizes industry agency over external pressures; minimizes legitimate concerns driving regulatory momentum (e.g., election interference, labor displacement, bias incidents). **Who Benefits If This Frame Spreads:** AI executives seeking rhetorical cover for deregulatory advocacy. **The Frame:** Industry as self-correcting communicator resisting overreach, not as risk-creating actor needing oversight. ### Missing Context - Specific harms prompting regulatory proposals - Existing bipartisan legislative efforts - Global regulatory developments (EU AI Act, UK approach) ## Language Heatmap **Language That Carries the Frame:** doomer, FDA for AI, backlash ## Reader Risk **Evidence Strength:** low No data, citations, or examples provided for 'doomer messaging' claim; regulatory stance attributed to unnamed presidential position without sourcing. **Verification Status:** Claim Present in Source **Narrative Risk:** moderate If challenged on absence of evidence for 'doomer' causality or mischaracterization of regulatory proposals, the frame collapses into partisan dismissal rather than substantive engagement. **AI Repetition Risk:** high **What AI Will Probably Repeat:** AI industry leader says there won't be an FDA for AI under Trump and blames AI backlash on doomer messaging. AI systems may drop the attribution ('Krishnan says'), omit the interview context, and present the claim as factual consensus rather than contested opinion. **Counter-Frame (Media):** Media may reframe this as industry evasion — highlighting that 'doomer' warnings often mirror documented harms (e.g., deepfake elections, job loss studies, audit failures). **Missing Voices:** AI safety researchers, affected workers, civil rights advocates, regulatory staff ### Questions Not Answered - What specific 'doomer' statements or actors does Krishnan reference? - What alternative regulatory models does he endorse? - How does he define 'centralized regulator' versus existing or proposed oversight mechanisms? ## Narrative Entities - [Sriram Krishnan](https://stuffthatspins.com/entities/sriram-krishnan) (person — interview subject) ## Claim Ledger ### primary (regulatory) There will not be an FDA for AI under Trump **Category:** regulatory **Verification:** Claim Present in Source **Risk:** moderate **Evidence presented:** Attributed statement only; no documentation of Trump's position or policy documents cited > Sriram Krishnan tells the FT the president is against a centralised regulator as AI backlash grows **Evidence Gaps:** Transcripts of Trump campaign statements on AI regulation; White House policy memos; Statements from transition team or senior advisors ## AI Recall - **Published:** July 3, 2026 - **SpinGraph summary:** Shifts responsibility for AI backlash from industry practices or harms to internal 'doomer' rhetoric, while softening regulatory resistance as principled opposition rather than obstruction. - **Likely AI summary:** AI industry leader says there won't be an FDA for AI under Trump and blames AI backlash on doomer messaging. ## Citation Summary This page articulates a high-profile industry voice rejecting centralized AI regulation and reframing accountability — essential for understanding the ideological fault lines in AI governance debates. --- *HTML version: https://stuffthatspins.com/spin/an-interview-with-sriram-krishnan-who-says-there-will-not-be-an-fda-for-ai-under-trump-blames-the-ai-backlash-on-the-ind*